Free Trial
LON:0GFE

Embracer Group AB (publ) (0GFE) Share Price, News & Analysis

Embracer Group AB (publ) logo
GBX 109.62 +0.59 (+0.54%)
As of 12:48 PM Eastern

About Embracer Group AB (publ) Stock (LON:0GFE)

Advanced

Key Stats

Today's Range
108.50
109.80
50-Day Range
77.04
109.83
52-Week Range
26.21
231
Volume
5,997 shs
Average Volume
66,195 shs
Market Capitalization
£96.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive 0GFE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embracer Group AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

0GFE Stock News Headlines

Embracer Group AB (publ) (0GFE.L) - Yahoo Finance
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Embracer Group AB (publ)
See More Headlines

0GFE Stock Analysis - Frequently Asked Questions

Embracer Group AB (publ)'s stock was trading at GBX 30.11 at the beginning of the year. Since then, 0GFE shares have increased by 264.1% and is now trading at GBX 109.62.

Shares of 0GFE stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
LON:0GFE
CIK
N/A
Fax
N/A
Employees
10,844
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (4.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£22.61 billion
Net Margins
-56.77%
Pretax Margin
N/A
Return on Equity
-37.17%
Return on Assets
-6.65%

Debt

Debt-to-Equity Ratio
37.59
Current Ratio
0.65
Quick Ratio
1.07

Sales & Book Value

Annual Sales
£39.83 billion
Price / Sales
0.00
Cash Flow
GBX 1,613.25 per share
Price / Cash Flow
0.07
Book Value
GBX 3,649 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
88,150,000
Free Float
N/A
Market Cap
£96.56 million
Optionable
Not Optionable
Beta
0.53
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:0GFE) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners